BMAL1 and nonpapillary renal cell carcinoma: Here, we demonstrate that BMAL1 forms a transcriptionally active heterodimer with HIF2α in ccRCC-derived cells and contributes to HIF2α-driven gene expression, cell and tumor growth, and sensitivity to growth suppression by the HIF2α antagonist PT2399.